Amgen, Takeda Acquisition Targets Involve Limited Exposure To Medicare – And Price Controls

 
• By Cathy Kelly
  
M&A perspectives
Recent M&A deals suggest industry is appreciating the impact of IRA, the new Medicare pricing law. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from Pink Sheet